Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
Clinical trial NCT03835949 · UNKNOWN
Trial details
- NCT number
- NCT03835949
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-16
- Primary completion
- 2022-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.